Search

EHA Friends' Fund

Together, we can change the lives of many and make greater strides in the treatment of patients with blood disorders.

Read more

Research

Research in hematology has dramatically improved our understanding of hematologic diseases and resulted in many innovative, groundbreaking discoveries.

Read more

Community and Stakeholder Committee

Current committee members
Raul Córdoba Mascuñano, Spain (Chair)
Donal McLornan, United Kingdom (Vice-Chair)
Meritxell Alberich Jordà, Czech Republic (EHA Board)
Margarita Guenova, Bulgaria (EHA Board)
Nuno Borges, United Kingdom (Representative, Young EHA Committee)
Ivo Touw, The Netherlands (Representative, Education Committee)
Regular members
Daniel Coriu, Romania
Andres Ferreri, Italy
Darko Antic,…

Read more

EHA-AHA joint membership

Save money and time by becoming a joint member of EHA and the Armenian Hematology Association. We've joined forces with the Armenian Hematology Association (AHA) to offer a special joint membership deal.

Read more

Targeting the B-cell Receptor in Aggressive B-cell Lymphomas

In collaboration with Dr. Lou Staudt, Pharmacyclics and associate investigators, we performed a clinical trial of a very potent inhibitor of Bruton Tyrosine Kinase (BTK) called ibrutinib.

Read more

The ‘i4MDS’ consortium looks to the future at its second general meeting

Feb 29 2024 Posted in Meeting reports Tagged i4MDS

The International Integrative Innovative Immunology for Myelodysplastic Neoplasms consortium—also known as ‘i4MDS’—held its second general meeting in The Hague from February 9–10, 2024.

Read more